ACTIVE

MEDISALE

Export PDF

Financial year 2024 · closed on 30/09/2024

Net result

-13,4 k €

-101.9% YoY

Revenue

33,3 M €

+7.5% YoY

Equity

1,9 M €

-0.7% YoY

Workforce

10,1 ETP

-11.4% YoY

What does MEDISALE do?

MEDISALE is a Private limited company incorporated in 1987. Its main activity is: Agents specialised in the sale of other particular products. Its registered office is in Gent. It employs on average 10,1 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0432.382.547

Incorporation

27/10/1987

Legal form

Private limited company

Registered office

Waalkens 11 box B
9030 Gent · FlandreSee on map

Contributed capital

18 592,01 €

Latest accounts

30/09/2024

Average workforce

10,1 ETP

Activities (NACE)

46180Agents specialised in the sale of other particular products· main 46180Agents specialised in the sale of other particular products 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 51180Passenger air transport 46341Wholesale of beverages+3

Joint committees (1)

Signals

Low riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2024		2023		2022		2021		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	33,3 M €	+7.5%	31 M €	+12.6%	27,5 M €		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–
EBITDA	184,2 k €	-81.5%	995,2 k €	+4.4%	953,7 k €	-8.0%	1 M €	+61.6%	641,2 k €	+222%	199,1 k €	-31.1%	289,1 k €	+186%	101,2 k €	+1007%	-11,2 k €	-233%	-3,4 k €	-51.4%	-2,2 k €	+29.8%	-3,2 k €	-132%	9,9 k €	-72.1%	35,4 k €	+68.1%	21 k €	+145%	-46,8 k €	-451%	13,3 k €	+5.0%	12,7 k €
Operating result	68,8 k €	-92.3%	899,3 k €	+1.8%	883,7 k €	-3.1%	911,7 k €	+61.9%	563 k €	+238%	166,5 k €	-21.3%	211,6 k €	+120%	96,3 k €	+865%	-12,6 k €	-192%	-4,3 k €	-36.0%	-3,2 k €	+22.9%	-4,1 k €	-145%	9,2 k €	-73.5%	34,7 k €	+64.8%	21 k €	+145%	-46,8 k €	-451%	13,3 k €	+5.0%	12,7 k €
Net result	-13,4 k €	-102%	715,6 k €	+8.4%	660,3 k €	+10.4%	598,2 k €	+27.7%	468,3 k €	+241%	137,3 k €	-24.3%	181,4 k €	+98.2%	91,6 k €	+524%	-21,6 k €	-264%	-5,9 k €	+17.5%	-7,2 k €	-22.2%	-5,9 k €	-165%	9 k €	-73.3%	33,9 k €	+33.6%	25,3 k €	+157%	-44,8 k €	-1051%	-3,9 k €	-178%	5 k €
Balance sheet
Equity	1,9 M €	-0.7%	1,9 M €	+23.7%	1,5 M €	+74.9%	882,1 k €	+211%	283,9 k €	+146%	115,6 k €	+17.6%	98,3 k €	+47.1%	66,8 k €	+165%	25,3 k €	-46.1%	46,8 k €	-11.2%	52,8 k €	-12.0%	59,9 k €	-8.9%	65,8 k €	+15.9%	56,8 k €	+53.8%	36,9 k €	+219%	11,6 k €	-79.5%	56,4 k €	-6.5%	60,3 k €
Total assets	7,2 M €	+0.9%	7,2 M €	+15.0%	6,2 M €	+34.4%	4,6 M €	-9.1%	5,1 M €	+55.5%	3,3 M €	+40.6%	2,3 M €	+108%	1,1 M €	+132%	483,3 k €	+154%	190,6 k €	+4.3%	182,6 k €	-9.3%	201,4 k €	+14.5%	176 k €	+5.4%	166,9 k €	-58.0%	397,3 k €	+1.4%	391,9 k €	+77.4%	220,9 k €	-44.3%	396,4 k €
Cash	147,9 k €	-51.7%	306,1 k €	-58.4%	735,3 k €	-16.5%	880,9 k €	+105%	429,4 k €	+439%	79,7 k €	-58.8%	193,3 k €	+181%	68,8 k €	+4295%	1,6 k €		–		–		165,8 €		–		640,9 €	-82.2%	3,6 k €	+39078%	9,2 €	-97.4%	358,7 €		–
Debts	5,3 M €	+1.3%	5,3 M €	+12.1%	4,7 M €	+24.9%	3,8 M €	-22.0%	4,8 M €	+52.3%	3,2 M €	+41.6%	2,2 M €	+112%	1,1 M €	+130%	458 k €	+219%	143,7 k €	+12.0%	128,4 k €	-9.3%	141,5 k €	+28.4%	110,2 k €	+0.0%	110,1 k €	-69.4%	360,4 k €	-5.2%	380,3 k €	+131%	164,5 k €	-50.7%	333,8 k €
Other
Workforce	10,1 ETP	-11.4%	11,4 ETP	-1.7%	11,6 ETP	+50.6%	7,7 ETP	+57.1%	4,9 ETP	+123%	2,2 ETP	+214%	0,7 ETP	+600%	0,1 ETP		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2024 · 1 active · 6 ended

Active mandates

DECURA PHARMA

Director · since 01 décembre 2016 · 0817.127.010

Represented by Andy Decuypere

Active

Ended mandates

DECAN CONSULT

Manager · since 13 septembre 2007 · 0878.303.821

Represented by Andy DECUYPERE

Ended

Decan Consult Comm.V

Manager · since 13 septembre 2007 · 0878.303.821

Represented by Andy Decuypere

Ended

Decan Consult CommV

Manager · since 13 septembre 2007 · 0878.303.821

Ended

Andy Decuypere

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
FIDELMED● Active	0698.912.120
Fidelmed Group● Active	1031.653.693
PHARMA FIDELMED● Active	0762.489.086

Annual accounts

Full financial information

	2024	2023	2022	2021	2019	2018
Type of account	Full model	Full model	Full model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/10/2023	01/10/2022	01/10/2021	01/01/2020	01/01/2019	01/01/2018
Closing of the financial year	30/09/2024	30/09/2023	30/09/2022	30/09/2021	31/12/2019	31/12/2018
Length of the financial year	12 months	12 months	12 months	21 months	12 months	12 months
Filing date	30/09/2025	30/10/2024	10/05/2023	19/04/2022	30/09/2020	30/09/2019
General meeting	30/04/2025	02/09/2024	02/05/2023	20/03/2022	01/09/2020	20/06/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	30/09/2024	30/04/2025	30/09/2025	Dutch	PDF
Full modelCorrection	30/09/2023	02/09/2024	30/10/2024	Dutch	PDF
Full model	30/09/2023	30/04/2024	30/04/2024	Dutch	PDF
Full model	30/09/2022	02/05/2023	10/05/2023	Dutch	PDF
Abridged model	30/09/2021	20/03/2022	19/04/2022	Dutch	PDF
Abridged model	31/12/2019	01/09/2020	30/09/2020	Dutch	PDF
Abridged model	31/12/2018	20/06/2019	30/09/2019	Dutch	PDF
Abridged model	31/12/2017	20/06/2018	19/10/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	31/08/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	31/08/2016	Dutch	PDF
Abridged model	31/12/2014	20/06/2015	29/09/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	12/09/2014	Dutch	PDF
Abridged model	31/12/2012	30/06/2013	30/09/2013	Dutch	PDF
Abridged model	31/12/2011	11/05/2012	31/07/2012	Dutch	PDF
Abridged model	31/12/2010	13/05/2011	29/11/2011	Dutch	PDF
Abridged model	31/12/2009	14/05/2010	23/08/2010	Dutch	PDF
Abridged model	31/12/2008	11/06/2010	17/06/2010	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	29/07/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	30/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2024 · 1 active · 6 ended

Active mandates

DECURA PHARMA

Director · since 01 décembre 2016 · 0817.127.010

Represented by Andy Decuypere

Active

Ended mandates

DECAN CONSULT

Manager · since 13 septembre 2007 · 0878.303.821

Represented by Andy DECUYPERE

Ended

Decan Consult Comm.V

Manager · since 13 septembre 2007 · 0878.303.821

Represented by Andy Decuypere

Ended

Decan Consult CommV

Manager · since 13 septembre 2007 · 0878.303.821

Ended

Andy Decuypere

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates18/02/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/04/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/02/2023
ONTSLAGEN - BENOEMINGEN
PDF
Registered office28/09/2021
MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates07/12/2020
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
PDF
Mandates30/01/2017
ONTSLAGEN - BENOEMINGEN
PDF
Other16/10/2014
BENAMING - DOEL - ALGEMENE VERGADERING
PDF
Registered office03/05/2013
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-13,4 k €↓
2023
Annual accounts 2023715,6 k €↑
2022
Annual accounts 2022660,3 k €↑
2021
Annual accounts 2021598,2 k €↑
2019
Annual accounts 2019468,3 k €↑
2018
Annual accounts 2018137,3 k €↓
2017
Annual accounts 2017181,4 k €↑
2016
Annual accounts 201691,6 k €↑
2015
Annual accounts 2015-21,6 k €↓
2014
Annual accounts 2014-5,9 k €↑
2013
Annual accounts 2013-7,2 k €↓
2012
Annual accounts 2012-5,9 k €↓
2011
Annual accounts 20119 k €↓
2010
Annual accounts 201033,9 k €↑
2009
Annual accounts 200925,3 k €↑
2008
Annual accounts 2008-44,8 k €↓
2007
Annual accounts 2007-3,9 k €↓
2006
Annual accounts 20065 k €
27/10/1987
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MEDISALE

Overview

What does MEDISALE do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline